Pulmonary interstitial emphysema treated by high-frequency oscillatory ventilation.

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Critical Care Medicine

Background:

• Pulmonary interstitial emphysema (PIE) and respiratory failure pose significant risks to low birth weight infants on conventional ventilation.
• Conventional ventilation strategies can be insufficient for managing severe PIE in vulnerable neonates.

Purpose of the Study:

• To evaluate the efficacy of high-frequency oscillatory ventilation (HFOV) in treating PIE and respiratory failure in low birth weight infants.
• To compare outcomes between infants treated with HFOV and those who did not survive.

Main Methods:

• Retrospective analysis of 27 low birth weight infants with PIE and respiratory failure treated with HFOV.
• Exclusion of 6 septic patients with shock from the primary analysis, focusing on 20 nonseptic patients.
• Assessment of initial improvement, oxygenation, ventilation, fraction of inspired oxygen, proximal airway pressure, and PIE resolution.

Main Results:

• All infants showed initial improvement with HFOV.
• Surviving infants demonstrated progressive improvement in oxygenation and ventilation with decreased support requirements and PIE resolution.
• Non-survivors experienced progressive chronic respiratory insufficiency and persistent PIE.

Conclusions:

• HFOV is an effective treatment for PIE in low birth weight infants, improving survival rates (80% in nonseptic patients).
• HFOV may decrease interstitial airleak by providing adequate ventilation at lower distal airway pressures.
• The findings support HFOV as a beneficial therapeutic option for neonates with PIE and respiratory failure.